Last Posted: Jul 21, 2017
- Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history
KG Chaffee et al, Genetics in Medicine, July 20, 2017 - Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer.
McAllister Florencia et al. Gastroenterology & hepatology 2017 May 13(5) 268-275 - Differential analysis of mutations in the Jewish population and their implications for diseases.
Einhorn Yaron et al. Genetics research 2017 May 99e3 - Lost in translation: returning germline genetic results in genome-scale cancer research
AL Johns et al, Genome Medicine, April 2017 - Family History Helped This Survivor Catch Pancreatic Cancer Early- About 10 percent of pancreatic cancer cases are connected to family history.
Celgene blog post, April 25, 2017 - Genetics of Pancreatic Cancer and Its Implications on Therapy.
Tatarian Talar et al. The Surgical clinics of North America 2016 Dec 96(6) 1207-1221 - Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.
Khan Mohammad Aslam Aslam et al. International journal of molecular sciences 2017 Apr 18(4) - Molecular Genetics of Pancreatic Neoplasms.
Hosoda Waki et al. Surgical pathology clinics 2016 Dec (4) 685-703 - DNA testing of pancreatic cyst fluid: is it ready for prime time?
Singhi Aatur D et al. The lancet. Gastroenterology & hepatology 2017 Jan 2(1) 63-72 - A meta-analysis of the diagnostic value of detecting K-ras mutation in pancreatic juice as a molecular marker for pancreatic cancer.
Yang Jing et al. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 16(4) 605-14 - New era in precision medicine for pancreatic cancer
Science, March 23, 2017 - Surveillance of patients with hereditary gastrointestinal cancer syndromes.
Moreira Leticia et al. Best practice & research. Clinical gastroenterology 2016 Dec 30(6) 923-935 - The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.
Martinez-Useros Javier et al. BioMed research international 2016 20161869304 - Circulating Tumor DNA May Serve as a Prognostic Marker in Pancreatic Cancer
J Cavallo, ASCO Post, December 20, 2016 - Circulating Tumor DNA May Serve as a Prognostic Marker in Pancreatic Cancer
J Cavallo, ASCO Post, December 20, 2016 - Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.
Levin Trine et al. Familial cancer 2016 Nov
.png)
No hay comentarios:
Publicar un comentario